China Deal Watch: Four Biotechs Kick Off May With Multiple In/Out Deals

 
• By Dexter Jie Yan

Four Chinese biotech companies reach in- and out-licensing deals covering antibody drug conjugates, small molecules and vaccines as they continue to pursue and develop innovation.

More and more Chinese Biotechs are teaming up with larger-scale domestic pharma companies for wider market access.
Licensing deals between Chinese and foreign biopharmas spiked in early May • Source: Alamy

More from China

More from Focus On Asia